Skip to main content

What the FDA labels say about taking them together

Oxycodone and pregabalin

Oxycodone's FDA label of May 6, 2026 names pregabalin in its drug interactions section, and pregabalin's label names oxycodone too. The oxycodone label: “Due to additive pharmacologic effect, the concomitant use of benzodiazepines or other CNS depressants including alcohol, increases the risk of respiratory depression, profound sedation, coma, and death.”

Check it at the source: the oxycodone FDA label on DailyMed (effective May 6, 2026, Rhodes Pharmaceuticals LLC); the pregabalin FDA label on DailyMed (effective April 15, 2025, Viatris Specialty LLC).

What does the oxycodone label say about pregabalin?

Oxycodone label, drug interactions

Benzodiazepines and Other Central Nervous System (CNS) Depressants Clinical Impact: Due to additive pharmacologic effect, the concomitant use of benzodiazepines or other CNS depressants, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death. … anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.

Oxycodone label, warnings and precautions

Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Profound sedation, respiratory depression, coma, and death may result from the concomitant use of oxycodone hydrochloride tablets with benzodiazepines and/or other CNS depressants, including alcohol (e.g., non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids [gabapentin or pregabalin], and other opioids).

Roxicodone label (SpecGx LLC, April 24, 2026), drug interactions

Benzodiazepines and Other Central Nervous System (CNS) Depressants Clinical Impact: Due to additive pharmacologic effect, the concomitant use of benzodiazepines or other CNS depressants, including alcohol, can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death. … anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids, alcohol.

Source: FDA drug label (Roxicodone, NDA021011), SpecGx LLC, effective April 24, 2026 (SPL set 5a8157d3-ba20-4abf-b0d4-6ad141b31d63), via openFDA

Source: FDA drug label (Oxycodone Hydrochloride), Rhodes Pharmaceuticals LLC, effective May 6, 2026 (SPL set a5162476-1217-41c0-bc7e-0a0f123f069f), via openFDA; the full label on DailyMed

What does the pregabalin label say about oxycodone?

Pregabalin label, drug interactions

Pharmacodynamics Multiple oral doses of LYRICA were co-administered with oxycodone, lorazepam, or ethanol.

Lyrica Cr label (Viatris Specialty LLC, March 12, 2026), drug interactions

Pharmacodynamics Although no pharmacokinetic interactions were seen with LYRICA and ethanol, lorazepam, or oxycodone, additive effects on cognitive and gross motor functioning were seen when LYRICA was co-administered with these drugs.

Source: FDA drug label (Lyrica Cr, NDA209501), Viatris Specialty LLC, effective March 12, 2026 (SPL set f280bbd8-2af2-444a-bd96-e409337ca6dd), via openFDA

Source: FDA drug label (Pregabalin, NDA022488), Mylan Pharmaceuticals Inc., effective April 12, 2025 (SPL set ebe34db4-816d-4f0a-adbb-826693662754), via openFDA

Source: FDA drug label (Lyrica), NDA021446 (Upjohn), as published by Viatris Specialty LLC, effective April 15, 2025 (SPL set d4734e7d-5079-455e-8ff5-8f4539c998a9), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

32Oxycodone generic labelers
52Pregabalin generic labelers
OxycodonePregabalin
Labeled forPainNerve pain and fibromyalgia, Seizures and epilepsy
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0884 per tablet 5 mg tablet$0.0571 per capsule 100 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?